Table 2.
Changes in different aspects of PCOS patients following different antidiabetic drugs as an add-on medication to metformin.
| Pioglitazone [19] | Pioglitazone [16] | Rosiglitazone [20] | Rosiglitazone [15] | Rosiglitazone [26] | Canagliflozin [32] | ||||||||||||||||||||
| Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | ||||||||||||||
| Met, 1000 mg/day | Met, 1000 mg/day + PGZ 30 mg/day | Met, 1500 mg/day | Met, 1500 mg/day + PGZ 30 mg/day | Met, 850 mg/day | Met, 850 mg/day + RSG 4 mg/day | Met, 1500 mg/day | Met, 1000 mg/day + RSG 4 mg/day | Met, 1500 mg/day | Met, 1500 mg/day + RSG 4 mg/day | Met, 2000 mg/day | Met, 2000 mg/day + CANA 100 mg/day | ||||||||||||||
| Pre | Post1 | Pre | Post1 | Pre | Post1 | Pre | Post1 | Pre | Post2 | Pre | Post2 | Pre | Post2 | Pre | Post2 | Pre | Post2 | Pre | Post2 | Pre | Post1 | Pre | Post1 | ||
|
| |||||||||||||||||||||||||
| Glycemic profile | FBS (mg/dL) | 90.9 (7) | 91.6 (6.6) | 92.5 (5.8) | 92 (6.1) | 97.2 (9) | 91.8 (5.4)∗ | 91.8 (9) | 90 (7.2) | 86.8 (2.4) | 84.4 (2.4) | 79.1 (2.9) | 84.7 (2.8) | 96.8 (7.4) | 91.6 (6.1)∗ | 98.4 (7.9) | 92.5 (10.4)∗ | 75.6 (18) | 73.8 (18) | 81 (14.4) | 70.2 (12.6) | 95.4 | 95.4 | 102.6 | 93.6∗ |
| HOMA-IR | 7.1 (3) | 3.9 (2)∗ | 6.2 (2.6) | 3.8 (2.1)∗ | 4.2 (2.7) | 2.3 (1.2)∗ | 2.7 (1.8) | 1.6 (0.8)∗ | NR | NR | NR | NR | 5.4 (1.9) | 3.6 (1.3)∗ | 5.5 (2) | 3.6 (1.5)∗ | 5 (1.9) | 2.9 (1.3)∗ | 5.4 (2) | 2.2 (1.2)∗ | 4.25 | 3.51∗ | 5.7 | 3.14∗ | |
|
| |||||||||||||||||||||||||
| Anthropometric measures | BW (kg) | 76.7 (16.8) | 76.5 (16.3)∗ | 75.7 (12.9) | 74.6 (12)∗ | 71.3 (11.2) | 71 (12.8) | 72.6 (9.4) | 71.5 (9.8) | 62.1 (0.6) | 61.4 (0.3) | 62.1 (0.7) | 62.3 (0.4) | 70 (8) | 63.2 (7)∗ | 70 (8.2) | 66.4 (8)∗ | NR | NR | NR | NR | 74.7 (8.9) | 72.5 (10)∗ | 81.2 (9.8) | 75.4 (8.7)∗ |
| BMI | 30.1 (6.6) | 29.9 (6.5)∗ | 28.8 (5.1) | 28.3 (4.6)∗ | 27.5 (3.6) | 27.4 (4.4) | 28.5 (3.2) | 28 (3.4) | 24.6 (0.2) | 24.3 (0.1) | 24.6 (0.3) | 24.6 (0.1) | 27.7 (2) | 25 (1.8)∗ | 27.3 (2.1) | 25.9 (2.2)∗ | NR | NR | NR | NR | 29.3 (3.2) | 27.1 (3.5)∗ | 31.1 (3) | 28.6 (2.9)∗ | |
| WC (cm) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 93.4 (7.2) | 89.5 (7.5)∗ | 92.5 (7.5) | 90.2 (7)∗ | NR | NR | NR | NR | NR | NR | NR | NR | |
| WHR | NR | NR | NR | NR | 0.83 (0.03) | 0.83 (0.04) | 0.82 (0.04) | 0.82 (0.05) | 0.8 (0.01) | 0.8 | 0.81 (0.01) | 0.8 | 0.93 (0.06) | 0.89 (0.06)∗ | 0.93 (0.06) | 0.9 (0.06)∗ | NR | NR | NR | NR | NR | NR | NR | NR | |
|
| |||||||||||||||||||||||||
| Lipid profile | TG (mg/dL) | NR | NR | NR | NR | 140.3 (58.2) | 147 (78.9) | 131 (59.3) | 114.3 (78.5) | NR | NR | NR | NR | 160.1 (53.1) | 130 (53)∗ | 162 (54) | 114.1 (60)∗ | 327.4 (70.8) | 194.7 (62)∗ | 327.4 (44.2) | 177 (53.1)∗ | 131.8 | 126.5 | 136.3 | 106.1∗ |
| TC (mg/dL) | NR | NR | NR | NR | 215 (36.5) | 209.7 (37.2) | 196 (36.6) | 197 (35.6) | NR | NR | NR | NR | 175.3 (35.5) | 158.3 (42.4)∗ | 173.7 (33.6) | 145.9 (29.3)∗ | NR | NR | NR | NR | 183 (24.3) | 175.3 (20) | 189.2 (36) | 175.3 (30.9)∗ | |
| HDL-C (mg/dL) | NR | NR | NR | NR | 51.1 (12.1) | 52.9 (11) | 52.2 (12.2) | 55.7 (13.2) | NR | NR | NR | NR | 49.8 (7.34) | 57.1 (9.27)∗ | 50.5 (10) | 53.3 (10.4)∗ | NR | NR | NR | NR | NR | NR | NR | NR | |
| LDL-C (mg/dL) | NR | NR | NR | NR | 131.8 (26.7) | 127 (28) | 126.9 (33.5) | 124 (29.8) | NR | NR | NR | NR | 112.7 (30.5) | 86.5 (31.6)∗ | 113.5 (22.4) | 85.7 (30.9)∗ | 104.2 (11.6) | 88.8 (7.7)∗ | 104.2 (11.6) | 73.3 (7.7)∗ | 116.2 (20.8) | 109.2 (18.9) | 118.1 (37.4) | 109.2 (27) | |
|
| |||||||||||||||||||||||||
| Hormonal profile | LH (IU/L) | 5.7 (3.7) | 4.9 (2.2) | 6.6 (4.49) | 5.1 (2.5)∗ | 7.9 (2.3) | 6.3 (2.4)∗ | 6.8 (2.7) | 6.4 (2.2) | NR | NR | NR | NR | NR | NR | NR | NR | 11.4 (2.1) | 4 (1.2)∗ | 12.1 (2.2) | 3.2 (0.2)∗ | 11.6 | 10.27 | 10.8 | 8.59 |
| FSH (IU/L) | 8.4 | 6.2 (3.8)∗ | 8.7 (6.7) | 6.1 (3.8)∗ | 5.2 (1.7) | 5.5 (1.4) | 5.6 (2.2) | 7 (2.2)∗ | NR | NR | NR | NR | NR | NR | NR | NR | 3.5 (1.5) | 3.3 (1.6) | 3.6 (1.4) | 3.3 (1.4) | 6 (1.6) | 5.36 (1.9) | 6.6 (1.5) | 5.84 (2.2) | |
| Prolactin (ng/mL) | 376.5 (185.4) | 261.2 (131.1)∗ | 239.4 (136.6) | 199.4 (96.4)∗ | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
| Testosterone (ng/mL) | 0.32 (0.1) | 0.19 (0.09)∗ | 0.28 (0.14) | 0.18 (0.07)∗ | 0.7 (0.2) | 0.6 (0.18)∗ | 0.6 (0.2) | 0.6 (0.1) | 1.1 (0.11) | 0.37 (0.04) | 1.9 (0.13) | 0.41 (0.06) | 0.66 (0.17) | 0.5 (0.18)∗ | 0.65 (0.25) | 0.46 (0.19)∗ | 0.57 (0.08) | 0.46 (0.08)∗ | 0.57 (0.11) | 0.37 (0.11)∗ | 0.89 | 0.71∗ | 0.95 | 0.53∗ | |
| DHEA-S (mg/L) | NR | NR | NR | NR | 1.5 (0.7) | 1.4 (0.5) | 1.4 (0.7) | 1.5 (0.8) | 3.3 (0.35) | 3 (0.39) | 2.9 (0.41) | 4.1 (0.51) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
|
| |||||||||||||||||||||||||
| BP | SBP (mmHg) | NR | NR | NR | NR | NR | NR | NR | NR | 123.9 (0.6) | 119.5 (0.7) | 123.2 (0.7) | 118.7 (0.8) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR |
| DBP (mmHg) | NR | NR | NR | NR | NR | NR | NR | NR | 82.9 (0.6) | 81.4 (0.5) | 83.6 (0.7) | 81.5 (0.6) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |
|
| |||||||||||||||||||||||||
| Sitagliptin [21] | Sitagliptin [24] | Exenatide [22] | Exenatide [27] | Exenatide [29] | |||||||||||||||||||||
| Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | ||||||||||||||||
| Met 1000 mg/day | Met, 1000 mg/day + SITA 100 mg/day | Met, 2000 mg/day | Met, 2000 mg/day + SITA 100 mg/day | Met, 2000 mg/day | Met, 2000 mg/day + EX 20 μg/day | Met, 1500 mg/day | Met, 1500 mg/day + EX 2 mg/week | Met, 2000 mg/day | Met, 2000 mg/day + EX 20 μg/day | ||||||||||||||||
| Pre | Post3 | Pre | Post3 | Pre | Post1 | Pre | Post1 | Pre | Post2 | Pre | Post2 | Pre | Post1 | Pre | Post1 | Pre | Post1 | Pre | Post1 | ||||||
|
| |||||||||||||||||||||||||
| Glycemic profile | FBS (mg/dL) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 93.6 (8.3) | 93.4 (9.2) | 93.8 (10.2) | 88.7 (8.4)∗ | NR | NR | NR | NR | ||||
| HOMA-IR | 4.09 (0.71) | 3.43 (0.47)∗ | 3.86 (0.79) | 3.39 (0.61)∗ | 6.1 (7.1) | 2.9 (1.8) | 3.1 (1.3) | 2.1 (1.5) | 6.03 (0.96) | 5.7 (0.7) | 4.3 (1) | 3.5 (0.7) | 4.49 (1.1) | 4.8 (2.1) | 5.3 (3) | 4.7 (1.5) | NR | NR | NR | NR | |||||
|
| |||||||||||||||||||||||||
| Anthropometric measures | BW (kg) | NR | NR | NR | NR | 101.2 (12.1) | 105.9 (13.7)∗ | 100.4 (12.9) | 101.4 (14) | 113.4 (7) | 111.8 (6) | 112 (8) | 106.4 (6) | 79.1 (10.8) | 77.05 (9.75)∗ | 82.34 (11.42) | 78.57 (10.94)∗ | 80 (8.8) | 76 (10)∗ | 83.2 (13) | 76.6 (13.2)∗ | ||||
| BMI | NR | NR | NR | NR | 37.8 (4.7) | 39.5 (5)∗ | 34.8 (5.4) | 35.1 (5.7) | 43.3 (2) | 42.3 (2) | 40.9 (2) | 39.2 (2) | 30.4 (3.16) | 29.63 (2.8)∗ | 30.8 (3.41) | 29.4 (3.32)∗ | 29.64 (3.6) | 28.2 (3.6)∗ | 31.6 (4.67) | 29.17 (4.8)∗ | |||||
| WC (cm) | NR | NR | NR | NR | 106.8 (9.5) | 108.8 (12.8) | 105.3 (12.7) | 103.3 (12.5) | NR | NR | NR | NR | 96.6 (9.1) | 95 (8.1)∗ | 97.3 (9.6) | 92.7 (8.7)∗ | NR | NR | NR | NR | |||||
| WHR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |||||
|
| |||||||||||||||||||||||||
| Lipid profile | TG (mg/dL) | NR | NR | NR | NR | 115 (44.2) | 123.9 (44.2) | 132.7 (61.9) | 141.6 (70.8) | 155 (15) | 188 (17) | 135 (15) | 126 (17) | 150.4 | 217.7∗ | 115 | 177∗ | 137.1 (97.3) | 122.1 (11.5)∗ | 176.1 (0.67) | 105.3 (49.5)∗ | ||||
| TC (mg/dL) | NR | NR | NR | NR | 185.3 (38.6) | 189.2 (42.4) | 189.2 (38.6) | 189.2 (42.4) | 188 (9) | 197 (9) | 212 (9) | 196 (9) | 198.8 (33.6) | 217.7 (34)∗ | 190.7 (30.1) | 198 (38.2) | 177.2 (32) | 179.9 (7.7) | 181.8 (29.3) | 177.6 (25.4) | |||||
| HDL-C (mg/dL) | NR | NR | NR | NR | 50.2 (7.7) | 54 (7.7) | 46.33 (7.7) | 50.2 (7.7)∗ | 41.4 (2) | 39.7 (1.7) | 46.8 (2) | 46.1 (1.7) | 44 (8.5) | 56 (13.9)∗ | 45.9 (9.2) | 55.6 (13.1)∗ | 45.1 (5.8) | 47.8 (2.8) | 43.6 (6.3) | 43.2 (7.14) | |||||
| LDL-C (mg/dL) | NR | NR | NR | NR | 112 (34.7) | 112 (34.7) | 115.8 (34.7) | 119.7 (30.9) | 115.6 (8) | 119.5 (8) | 139.2 (8) | 124.6 (8) | 130.5 (27.4) | 130.1 (30.1) | 124.3 (23.5) | 115 (32) | 116.6 (25.5) | 97.3 (14.6)∗ | 129.7 (28.2) | 108.5 (19.7)∗ | |||||
|
| |||||||||||||||||||||||||
| Hormonal profile | LH (IU/L) | NR | NR | NR | NR | 6.4 (4.3) | 5.8 (2.7) | 7.9 (8.1) | 8.8 (14.5) | NR | NR | NR | NR | NR | NR | NR | NR | 7.8 (5.6) | 6.1 (2.6)∗ | 7.5 (3.7) | 6.5 (2.2)∗ | ||||
| FSH (IU/L) | 4.99 (0.72) | 5.98 (0.96) | 5.31 (1.1) | 5.83 (0.88) | 3.6 (1.6) | 4.9 (2)∗ | 5.5 (2.3) | 5.2 (3) | NR | NR | NR | NR | NR | NR | NR | NR | 6.3 (1.5) | 6.2 (1.8) | 6.4 (1.9) | 6.5 (1) | |||||
| Prolactin (ng/mL) | 13.56 (0.45) | 14.7 (0.69) | 14.25 (0.69) | 15.63 (1.15) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |||||
| Testosterone (ng/mL) | NR | NR | NR | NR | 0.51 (0.17) | 0.4 (0.17) | 0.37 (0.17) | 0.37 (0.2) | 0.56 (0.08) | 0.53 (0.07) | 0.59 (0.08) | 0.41 (0.07) | 0.78 (0.22) | 0.56 (0.2)∗ | 0.74 (0.29) | 0.57 (0.25)∗ | 0.63 (0.28) | 0.53 (0.23)∗ | 0.67 (0.21) | 0.54 (0.27)∗ | |||||
| DHEA-S (mg/L) | 2.29 (0.72) | 0.66 (0.09) | 2.81 (1.18) | 0.58 (0.12) | NR | NR | NR | NR | 1.42 (0.19) | 1.61 (0.2) | 1.23 (0.2) | 1.21 (0.2) | 2.65 (1.2) | 2.61 (1.2) | 2.63 (1.2) | 2.61 (1.3) | 2.55 (1.1) | 2.46 (0.53) | 2.48 (0.81) | 2.34 (0.66) | |||||
|
| |||||||||||||||||||||||||
| BP | SBP (mmHg) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | ||||
| DBP (mmHg) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |||||
|
| |||||||||||||||||||||||||
| Saxagliptin [23] | Saxagliptin [28] | Liraglutide [25] | Liraglutide [31] | Beinaglutide [30] | |||||||||||||||||||||
| Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | Control | Intervention | ||||||||||||||||
| Met, 2000 mg/day | Met, 2000 mg/day + SAXA 5 mg/day | Met, 2000 mg/day | Met, 2000 mg/day + SAXA 5 mg/day | Met, 2000 mg/day | Met, 2000 mg/day + LIR 1.2 mg/day | Met, 2000 mg/day | Met, 2000 mg/day + LIR 1.2 mg/day | Met, 1700 mg/day | Met, 1700 mg/day + beinaglutide 0.6 mg/day | ||||||||||||||||
| Pre | Post4 | Pre | Post4 | Pre | Post2 | Pre | Post2 | Pre | Post1 | Pre | Post1 | Pre | Post5 | Post1 | Pre | Post5 | Post1 | Pre | Post1 | Pre | Post1 | ||||
|
| |||||||||||||||||||||||||
| Glycemic profile | FBS (mg/dL) | 100.8 (10.2) | 97.2 (12.6) | 100.8 (9.9) | 90 (6.5) | 101.1 | 90.1∗ | 105.1 | 92.5∗ | NR | NR | NR | NR | 98.6 (9.3) | NR | 93.6 (5.7)∗ | 102.6 (16.7) | NR | 90.9 (7.2)∗ | 95.2 (5) | 93.8 (15.1)∗ | 99.1 (5.9) | 92.1 (5.2)∗ | ||
| HOMA-IR | 6.8 (3.6) | 5.9 (3.7) | 5 (2) | 3.6 (2.1) | 3.56 | 2.29∗ | 4.22 | 2.45∗ | 3.8 (2.8) | 2.5 (1.7) | 1.7 (3.6) | 2.1 (2.1) | 4.53 (3.07) | NR | 2.86 (2.05)∗ | 4.85 (2.09) | NR | 2.62 (1.05)∗ | 5.39 (1.86) | 4.96 (2.74) | 5.68 (1.94) | 4.98 (1.73)∗ | |||
|
| |||||||||||||||||||||||||
| Anthropometric measures | BW (kg) | NR | NR | NR | NR | 67.9 | 65.1∗ | 69.3 | 67∗ | 103.2 (6.3) | 102 (6.8) | 105.5 (20.6) | 99 (21.2) | 76.5 (12.4) | 74.1 (12.4)∗ | 71.4 (11.5)∗ | 79 (8.4) | 73.2 (7.7)∗ | 69.9 (7.2)∗ | 72.5 (5.9) | 70 (3.8)∗ | 72.9 (6.8) | 68.4 (5.9)∗ | ||
| BMI | 42.1 (7.3) | 42 (7.7) | 43.8 (10.5) | 42 (10.2) | 26.4 | 25.32∗ | 26.38 | 25.46∗ | 36.6 (3.5) | 36.1 (3.8) | 37.6 (5.1) | 35.3 (5.5) | 28.8 (4.2) | 27.9 (4.2)∗ | 26.8 (3.7)∗ | 29.6 (3.4) | 27.4 (3)∗ | 26.2 (2.7)∗ | 29 (2.3) | 27 (1)∗ | 28.8 (2.9) | 25.9 (2.7)∗ | |||
| WC (cm) | 111 (11) | 109 (13) | 111 (15) | 106 (16) | 82.8 | 79.9∗ | 84.7 | 81.5∗ | 122.3 (7) | 120.7 (7.8) | 121.9 (17.7) | 116.4 (18.4) | NR | NR | NR | NR | NR | NR | 89.7 (5.4) | 89.9 (5.7) | 96.8 (6.9) | 94.6 (5.4)∗ | |||
| WHR | NR | NR | NR | NR | 0.85 (0.06) | 0.83 (0.05)∗ | 0.86 (0.06) | 0.83 (0.05)∗ | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 0.95 (0.13) | 0.94 (0.12) | 0.99 (0.06) | 0.98 (0.06) | |||
|
| |||||||||||||||||||||||||
| Lipid profile | TG (mg/dL) | 134.5 (56.6) | 164.6 (61.9) | 142.5 (53.1) | 117.7 (35.4) | 116.8 | 79.6∗ | 118.5 | 84∗ | 141.2 (32.7) | 115 (32.7) | 123.9 (26.5) | 123.9 (32.7) | NR | NR | NR | NR | NR | NR | 230 (66.3) | 215 (48.6)∗ | 255.7 (72.5) | 237.1 (65.5)∗ | ||
| TC (mg/dL) | 189.1 (27) | 181.4 (23.9) | 189.1 (29.3) | 177.6 (20.8) | 190.7 | 176∗ | 185.3 | 174.5∗ | 181.5 (23.1) | 177.6 (15.4) | 204.6 (42.4) | 177.6 (30.9) | NR | NR | NR | NR | NR | NR | 174.5 (24.3) | 171.8 (32) | 185.7 (17.3) | 184.1 (18.5) | |||
| HDL-C (mg/dL) | 43.2 (13.5) | 40.9 (11.6) | 40.1 (9.6) | 40.9 (7.7) | 52.1 | 54.4∗ | 47.8 | 51 | 42.4 (7.7) | 46.3 (7.7) | 50.2 (15.4) | 42.4 (7.7) | NR | NR | NR | NR | NR | NR | 43.6 (16.6) | 50.9 (12.3)∗ | 41.3 (7.3) | 42.8 (9.2) | |||
| LDL-C (mg/dL) | 118.1 (23.1) | 108.8 (23.1) | 122 (21.6) | 113.9 (19.3) | 128.1 (26.6) | 111.5 (17.3)∗ | 131.2 (28.1) | 115 (15.8)∗ | 112 (23.1) | 112 (19.3) | 131.3 (30.9) | 112 (30.9) | NR | NR | NR | NR | NR | NR | 114.3 (13.9) | 112.3 (11.2) | 117.3 (14.6) | 115 (20.4) | |||
|
| |||||||||||||||||||||||||
| Hormonal profile | LH (IU/L) | NR | NR | NR | NR | 11.74 | 7.55∗ | 9.62 | 7.68 | NR | NR | NR | NR | 11.97 (4.2) | 12.08 (6.47) | 9.77 (5.81) | 12.09 (5.2) | 9.54 (4.5) | 6.61 (4.7)∗ | 10 (3) | 10.4 (2.5) | 10.8 (4.6) | 10.1 (3.9) | ||
| FSH (IU/L) | NR | NR | NR | NR | 8.18 | 5.92∗ | 7.66 | 5.97∗ | NR | NR | NR | NR | 6.03 (1.48) | 5.91 (1.72) | 5.28 (2.11) | 6.22 (1.4) | 5.15 (1.9)∗ | 4.4 (2.6)∗ | 5.8 (1.1) | 5.9 (0.8) | 5.7 (1) | 5.8 (0.9) | |||
| Prolactin (ng/mL) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | 10.8 (4.2) | 10.8 (4.5) | 13 (5.7)∗ | 10.2 (3.6) | 10.6 (4.6) | 12.9 (4.9)∗ | NR | NR | NR | NR | |||
| Testosterone (ng/mL) | 0.42 (0.17) | 0.31 (0.12) | 0.42 (0.18) | 0.31 (0.21) | 0.74 | 0.6∗ | 0.75 | 0.65∗ | 0.49 (0.28) | 0.43 (0.26) | 0.6 (0.37) | 0.46 (0.2) | 0.84 (0.25) | 0.81 (0.35) | 0.79 (0.31) | 0.79 (0.2) | 0.7 (0.2) | 0.62 (0.2)∗ | NR | NR | NR | NR | |||
| DHEA-S (mg/L) | 1.76 (0.55) | 1.7 (0.55) | 1.46 (0.81) | 1.4 (0.66) | NR | NR | NR | NR | 2.28 (1.17) | 2.13 (1.32) | 2.1 (0.77) | 1.95 (0.88) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |||
|
| |||||||||||||||||||||||||
| BP | SBP (mmHg) | 135.7 (7) | 133 (11) | 131.6 (12) | 131 (13) | NR | NR | NR | NR | 121.9 (13.1) | 116.8 (14.6) | 125 (13) | 126.7 (18.2) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | ||
| DBP (mmHg) | 88.6 (8) | 85.4 (9.8) | 82.5 (13) | 83.5 (8.9) | NR | NR | NR | NR | 74.1 (12.2) | 70.2 (9.4) | 80 (6.6) | 79.9 (7.8) | NR | NR | NR | NR | NR | NR | NR | NR | NR | NR | |||
1After 12 weeks of intervention. 2After 24 weeks of intervention. 3After 8 weeks of intervention. 4After 16 weeks of intervention. 5After 4 weeks of intervention. ∗Significant differences between before and after intervention. Values are mean (standard deviation) if available. Pre, before intervention; post, after intervention; FBS, fasting blood sugar; BW, body weight; BMI, body mass index; WC, waist circumference; WHR, waist-to-hip ratio; TG, triglyceride; TC, total cholesterol; SBP, systolic blood pressure; DBP, diastolic blood pressure; Met, metformin; PGZ, pioglitazone; RSG, rosiglitazone; CANA, canagliflozin; SITA, sitagliptin; EX, exenatide; SAXA, saxagliptin; LIR, liraglutide; NR, not reported.